Miller MC

No ORCID on file · 4 papers in corpus
observational 2012
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2011.12.029

OBJECTIVE: The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer. This study measured the HE4 and CA125 levels in women with benign gynecological disorders. STUDY DESIGN: Sera were obtained from women prior to surger…

meta-analysis 2012
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2011.12.028

OBJECTIVE: The purpose of this study was to establish normal ranges for human epididymis protein 4 (HE4) serum levels in healthy women. STUDY DESIGN: HE4 levels were measured in healthy women and analyzed by age, menopausal status, and pre…

nonrandomized-trial 2011
Obstetrics and gynecology ·doi:10.1097/aog.0b013e318224fce2

OBJECTIVE: It is often difficult to distinguish a benign pelvic mass from a malignancy and tools to help referring physician are needed. The purpose of this study was to validate the Risk of Ovarian Malignancy Algorithm in women presenting …

nonrandomized-trial 2009
Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.08.031

INTRODUCTION: Patients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validate a predictive model to assess the risk f…